Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 139

Results For "GTHE"

1489 News Found

Laurus Labs acquires stake in IIT Bombay incubated ImmunoACT
News | November 20, 2021

Laurus Labs acquires stake in IIT Bombay incubated ImmunoACT

ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.


PM Modi hails pharma industry for its innovation
News | November 19, 2021

PM Modi hails pharma industry for its innovation

Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world


Indian nutraceutical market is expected to touch US $ 18 bn by 2025: Dr R.B Smarta
interviews | November 18, 2021

Indian nutraceutical market is expected to touch US $ 18 bn by 2025: Dr R.B Smarta

The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector


Cipla launches Spirofy for early diagnosis of COPD
Medical Device | November 17, 2021

Cipla launches Spirofy for early diagnosis of COPD

It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)


International Society of Pharmacovigilance opens South Asia chapter
Public Health | November 16, 2021

International Society of Pharmacovigilance opens South Asia chapter

The aim is to support Pharmacovigilance programme across the countries in the region


USAID announces Momentum country programme
Public Health | November 15, 2021

USAID announces Momentum country programme

The initiative will engage adolescents and youth of India in decisions about their reproductive health


Bristol Myers neoadjuvant Opdivo (nivolumab) plus chemotherapy assists cancer patients effectively
Biotech | November 09, 2021

Bristol Myers neoadjuvant Opdivo (nivolumab) plus chemotherapy assists cancer patients effectively

Positive results reinforce the improved efficacy seen with Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer and melanoma


Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
Biotech | November 08, 2021

Meiji Seika Pharma to build new facility in Bangalore to expand CMO business

The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23


Shilpa Biologics permitted to conduct Phase 1 study on NavAlbumin
Biotech | November 05, 2021

Shilpa Biologics permitted to conduct Phase 1 study on NavAlbumin

The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent


Sun Pharma Q2FY22 PAT jumps to Rs 2088.73 Cr
News | November 03, 2021

Sun Pharma Q2FY22 PAT jumps to Rs 2088.73 Cr

Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.